Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078650 | SCV000110506 | benign | not specified | 2013-10-03 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000078650 | SCV000269756 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.Thr533Met in exon 14 of RPGR: This variant is not expected to have clinical si gnificance because it has been identified in 2.9% (197/6728) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs41312104). |
Prevention |
RCV000078650 | SCV000303613 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000476587 | SCV000557306 | benign | Primary ciliary dyskinesia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000085069 | SCV001159193 | benign | not provided | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000085069 | SCV001825373 | likely benign | not provided | 2019-07-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000476587 | SCV002706314 | benign | Primary ciliary dyskinesia | 2014-12-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000078650 | SCV004804408 | likely benign | not specified | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000085069 | SCV005209233 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Retina International | RCV000085069 | SCV000117206 | not provided | not provided | no assertion provided | not provided |